Radius Health Obtains $91,000,000 New Funding

  • Feed Type
  • Date
    5/24/2011
  • Company Name
    Radius Health
  • Mailing Address
    300 Technology Square Fifth Floor Cambridge, MA 02139
  • Company Description
    Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women’s health.
  • Website
    http://www.radiuspharm.com
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $91,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Radius will use the proceeds primarily to fund Phase 3 clinical development of the subcutaneous injection form of BA058, the company’s novel, proprietary PTHrP (parathyroid hormone-related protein) analog, for the treatment of osteoporosis.
  • M&A Terms
  • Venture Investor
    GE Healthare Financial Services
  • Venture Investor
    Oxford Finance Corporation
  • Venture Investor
    BB Biotech Ventures
  • Venture Investor
    Brookside Capital
  • Venture Investor
    Saints Capital
  • Venture Investor
    Nordic Biotech Advisors
  • Venture Investor
    MPM Capital
  • Venture Investor
    The Wellcome Trust
  • Venture Investor
    HealthCare Ventures
  • Venture Investor
    Scottish Widows Investment Partnership

By posting a comment, you agree to our terms and conditions.